Home / News / India News / Article /
'The judgment will change the cancer scene in India'
Updated On: 02 April, 2013 06:59 AM IST | | Vinod Kumar Menon
Founder chairman and CEO of the Cancer Patients Aid Association hails the SC's ruling rejecting the attempt of Novartis to patent an updated version of a cancer drug
Listen to this article :
In a milestone judgment that will be regarded as the gold standard to deal with patent bids by multinational pharmaceutical companies in India, the Supreme Court on Monday rejected Swiss drug maker Novartis AG’s plea to patent an expensive anticancer drug Glivec.

Novartis called the ruling a “setback for patients,” and said patent protection is crucial to fostering investment in research to develop new and better drugs. Pic/AFPu00a0
Read Next Story


